Pain response during heel lancing Signs and Symptoms Pain response
Conditions
Interventions
After obtained informed consent from the mother and the father, the neonate will be randomised to intervention (father first mother second) or control (mother first father second). Kangaroo care invol
one with the mother and the other one with the father. The measures will be taken for the entire heel lance procedure (one minute of baseline isolette, one minute of baseline kangaroo, one minute of w
Sponsors
McGill University (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Born between 28 0/7 and 35 6/7 weeks of gestation, either sex 2. Obtained consent 3. Receiving at least two heel lances prior to discharge 4. Within 10 days of hospitalisation 5. Stable according to Neonatal Intensive Care Unit criteria
Exclusion criteria
Exclusion criteria: 1. Genetic or major congenital disorders 2. Requiring surgery before or during the study period 3. Receiving analgesics or paralysing agents 4. Intra-ventricular haemorrhage (IVH) grade III+ or periventricular leukomalacia (PVL) as confirmed by ultrasound
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain measured with Premature Infant Pain Profile (PIPP), repeated over 30 second blocks 2. Facial actions of the PIPP scored according to Neonatal Facial Coding System (NFCS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Timing for return to physiologic baseline measured as the preterm neonate's return to baseline HR after the heel lance procedure procured via an oximeter placed on the unaffected foot of the neonate. | — |
Countries
Canada
Outcome results
None listed